Electrophorus electricus isolate fEleEle1 chromosome 26, fEleEle1.pri, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Gymnotiformes; Gymnotoidei; Gymnotidae; Electrophorus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM023705.1.\nAssembly name: fEleEle1.pri\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2020/06/23. The original whole-genome shotgun project has the\naccession JABVME000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 17-MAR-2020\nAssembly Method :: FALCON v. 2018.31.08-03.06; FALCON-Unzip\n v. 7.0.1.66975; purge_dups v. v1;\n scaff10x v. 4.1.0; Bionano Solve DLS v.\n 3.4; Salsa HiC v. 2.2; Arrow smrtanalysis\n Pacbio polishing & gap filling v.\n SMRTLink7.0.1; longranger align v. 2.2.2;\n freebayes Illumina polishing v. 1.3.1;\n gEVAL manual curation v. 2020-03-17; VGP\n assembly pipeline individual v. 1.6\nAssembly Name :: fEleEle1.pri\nDiploid :: Principal pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 52.97x\nSequencing Technology :: PacBio Sequel I CLR; llumina NovaSeq;\n Arima Genomics Hi-C; Bionano Genomics DLS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Electrophorus electricus Annotation\n Release 101\nAnnotation Version :: 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 8.5\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Netherlands: Dejong Marinelife, Rotterdam
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC118240844, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC118240844, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC118240844, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 118 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 118 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ankyrin repeat domain-containing protein 29
vacuolar protein sorting-associated protein 4B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
vacuolar protein sorting-associated protein 4B-like isoform X1
vacuolar protein sorting-associated protein 4B-like, transcript variant X2
vacuolar protein sorting-associated protein 4B-like isoform X2
pleckstrin homology domain-containing family B member 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
pleckstrin homology domain-containing family B member 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
pleckstrin homology domain-containing family B member 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
pleckstrin homology domain-containing family B member 2-like isoform X1
pleckstrin homology domain-containing family B member 2-like isoform X2
uncharacterized protein KIAA1614, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein KIAA1614, transcript variant X6
uncharacterized protein KIAA1614 isoform X2
uncharacterized protein KIAA1614, transcript variant X8
uncharacterized protein KIAA1614 isoform X4
pleckstrin homology domain containing, family B (evectins) member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
pleckstrin homology domain containing, family B (evectins) member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
pleckstrin homology domain containing, family B (evectins) member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
pleckstrin homology domain-containing family B member 2 isoform X1
pleckstrin homology domain-containing family B member 2 isoform X2
uncharacterized protein KIAA1614, transcript variant X4
uncharacterized protein KIAA1614, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein KIAA1614, transcript variant X1
uncharacterized protein KIAA1614, transcript variant X2
uncharacterized protein KIAA1614, transcript variant X7
uncharacterized protein KIAA1614 isoform X1
uncharacterized protein KIAA1614 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
T-cell acute lymphocytic leukemia protein 1 homolog
PDZK1 interacting protein 1, transcript variant X2
PDZK1 interacting protein 1, transcript variant X1
PATJ crumbs cell polarity complex component, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
PATJ crumbs cell polarity complex component, transcript variant X2
PATJ crumbs cell polarity complex component, transcript variant X4
PATJ crumbs cell polarity complex component, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nuclear factor I/A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nuclear factor I/A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nuclear factor I/A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nuclear factor I/A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nuclear factor I/A, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nuclear factor I/A, transcript variant X9
nuclear factor I/A, transcript variant X11
nuclear factor I/A, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
nuclear factor I/A, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
nuclear factor I/A, transcript variant X10
nuclear factor I/A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
FRAS1-related extracellular matrix protein 1b
ATP synthase mitochondrial F1 complex assembly factor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
RAB3B, member RAS oncogene family, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 81 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
RAB3B, member RAS oncogene family, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 81 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RAB3B, member RAS oncogene family, transcript variant X3
nardilysin b (N-arginine dibasic convertase)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
axonemal dynein light chain domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
axonemal dynein light chain domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 163 member A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
family with sequence similarity 163 member A, transcript variant X3
family with sequence similarity 163 member A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
RAB GTPase activating protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
RAB GTPase activating protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
RAB GTPase activating protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
rab GTPase-activating protein 1-like isoform X1
rab GTPase-activating protein 1-like isoform X2
rab GTPase-activating protein 1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
RAB GTPase activating protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
RAB GTPase activating protein 1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
RAB GTPase activating protein 1-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
rab GTPase-activating protein 1-like isoform X4
rab GTPase-activating protein 1-like isoform X6
RAB GTPase activating protein 1-like, transcript variant X5
rab GTPase-activating protein 1-like isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein M
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
membrane-associated ring finger (C3HC4) 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 153 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X4
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X2
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X1
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma a, transcript variant X3
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X3
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ribonuclease P 21 subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ribonuclease P 21 subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ribonuclease P protein subunit p21 isoform X1
ribonuclease P protein subunit p21 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 26% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ankyrin repeat and MYND domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ankyrin repeat and MYND domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ankyrin repeat and MYND domain containing 1, transcript variant X4
ankyrin repeat and MYND domain containing 1, transcript variant X1
ankyrin repeat and MYND domain-containing protein 1 isoform X2
ankyrin repeat and MYND domain-containing protein 1 isoform X4
ankyrin repeat and MYND domain-containing protein 1 isoform X3
ankyrin repeat and MYND domain-containing protein 1 isoform X1
ankyrin repeat and MYND domain containing 1, transcript variant X5
ankyrin repeat and MYND domain-containing protein 1 isoform X5
ankyrin repeat and MYND domain containing 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ankyrin repeat and MYND domain-containing protein 1 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
hematopoietic SH2 domain-containing protein homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 105 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
lipoprotein lipase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 69 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
lipoprotein lipase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 70 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
lipoprotein lipase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 82 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
lipoprotein lipase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 10
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: disintegrin and metalloproteinase domain-containing protein 10
scaffold attachment factor B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
scaffold attachment factor B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
scaffold attachment factor B1 isoform X2
scaffold attachment factor B1 isoform X1
MALT paracaspase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
MALT paracaspase 2, transcript variant X1
39S ribosomal protein L54, mitochondrial
family with sequence similarity 32 member A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC113574482, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC113574482, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: Krueppel-like factor 2a
epidermal growth factor receptor pathway substrate 15-like 1a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
epidermal growth factor receptor pathway substrate 15-like 1a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
epidermal growth factor receptor substrate 15-like 1 isoform X2
epidermal growth factor receptor substrate 15-like 1 isoform X1
epidermal growth factor receptor pathway substrate 15-like 1a, transcript variant X4
epidermal growth factor receptor pathway substrate 15-like 1a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
epidermal growth factor receptor substrate 15-like 1 isoform X4
epidermal growth factor receptor substrate 15-like 1 isoform X3
epidermal growth factor receptor pathway substrate 15-like 1a, transcript variant X5
epidermal growth factor receptor substrate 15-like 1 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ring finger and CCCH-type domains 1a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ring finger and CCCH-type domains 1a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ring finger and CCCH-type domains 1a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ring finger and CCCH-type domains 1a, transcript variant X4
ring finger and CCCH-type domains 1a, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ring finger and CCCH-type domains 1a, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ring finger and CCCH-type domains 1a, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ring finger and CCCH-type domains 1a, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
serpin peptidase inhibitor, clade C (antithrombin), member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 42% coverage of the annotated genomic feature by RNAseq alignments
zinc finger and BTB domain containing 37
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 37
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
vascular cell adhesion molecule 1b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
vascular cell adhesion molecule 1b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
vascular cell adhesion protein 1b isoform X2
vascular cell adhesion protein 1b isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
cell division cycle 14Ab, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cell division cycle 14Ab, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cell division cycle 14Ab, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cell division cycle 14Ab, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cell division cycle 14Ab, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cell division cycle 14Ab, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cell division cycle 14Ab, transcript variant X3
dual specificity protein phosphatase CDC14AB isoform X7
dual specificity protein phosphatase CDC14AB isoform X4
dual specificity protein phosphatase CDC14AB isoform X2
dual specificity protein phosphatase CDC14AB isoform X1
dual specificity protein phosphatase CDC14AB isoform X6
dual specificity protein phosphatase CDC14AB isoform X5
dual specificity protein phosphatase CDC14AB isoform X3
dihydrolipoamide branched chain transacylase E2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial
leucine rich repeat containing 39, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
leucine rich repeat containing 39, transcript variant X2
leucine-rich repeat-containing protein 39
tRNA methyltransferase 13 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
tRNA methyltransferase 13 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tRNA methyltransferase 13 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
tRNA:m(4)X modification enzyme TRM13 homolog isoform X1
tRNA:m(4)X modification enzyme TRM13 homolog isoform X3
tRNA:m(4)X modification enzyme TRM13 homolog isoform X2
oxysterol binding protein-like 1A, transcript variant X1
oxysterol binding protein-like 1A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
oxysterol binding protein-like 1A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
oxysterol binding protein-like 1A, transcript variant X3
oxysterol-binding protein-related protein 1 isoform X1
oxysterol-binding protein-related protein 1 isoform X2
uncharacterized LOC113574551, transcript variant X2
uncharacterized LOC113574551, transcript variant X1
cystinosin, lysosomal cystine transporter, transcript variant X1
cystinosin, lysosomal cystine transporter, transcript variant X2
polymerase (DNA-directed), epsilon 4, accessory subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Tax1 (human T-cell leukemia virus type I) binding protein 3
nuclear receptor subfamily 2, group F, member 6b
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: nuclear receptor subfamily 2 group F member 6b
Usher syndrome 1C binding protein 1, transcript variant X2
Usher syndrome 1C binding protein 1, transcript variant X3
Usher syndrome 1C binding protein 1, transcript variant X1
Usher syndrome 1C binding protein 1, transcript variant X5
Usher syndrome 1C binding protein 1, transcript variant X4
colorectal mutant cancer protein isoform X2
colorectal mutant cancer protein isoform X3
colorectal mutant cancer protein isoform X1
colorectal mutant cancer protein isoform X5
colorectal mutant cancer protein isoform X4
BRISC and BRCA1 A complex member 1, transcript variant X1
BRISC and BRCA1 A complex member 1, transcript variant X2
BRISC and BRCA1 A complex member 1, transcript variant X3
plasmalemma vesicle associated protein b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
GTP binding protein 3, mitochondrial, transcript variant X2
GTP binding protein 3, mitochondrial, transcript variant X1
tRNA modification GTPase GTPBP3, mitochondrial isoform X1
tRNA modification GTPase GTPBP3, mitochondrial isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
DAZ associated protein 1, transcript variant X4
DAZ associated protein 1, transcript variant X3
DAZ associated protein 1, transcript variant X2
DAZ associated protein 1, transcript variant X1
NADH:ubiquinone oxidoreductase core subunit S7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 3
AT rich interactive domain 3A (BRIGHT-like), transcript variant X2
AT rich interactive domain 3A (BRIGHT-like), transcript variant X1
AT-rich interactive domain-containing protein 3A isoform X2
AT-rich interactive domain-containing protein 3A isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phospholipid-transporting ATPase ABCA1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
phospholipid-transporting ATPase ABCA1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
phospholipid-transporting ATPase ABCA1, transcript variant X1
phospholipid-transporting ATPase ABCA1 isoform X2
phospholipid-transporting ATPase ABCA1 isoform X3
phospholipid-transporting ATPase ABCA1 isoform X1
phospholipid-transporting ATPase ABCA1, transcript variant X4
phospholipid-transporting ATPase ABCA1 isoform X4
amyloid-beta A4 precursor protein-binding family A member 3, transcript variant X1
amyloid-beta A4 precursor protein-binding family A member 3, transcript variant X3
amyloid-beta A4 precursor protein-binding family A member 3, transcript variant X2
amyloid-beta A4 precursor protein-binding family A member 3 isoform X1
amyloid-beta A4 precursor protein-binding family A member 3 isoform X2
FYN-binding protein 1, transcript variant X2
FYN-binding protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 26-like, transcript variant X2
mediator of RNA polymerase II transcription subunit 26-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 26-like isoform X2
mediator of RNA polymerase II transcription subunit 26-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
trimeric intracellular cation channel type A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CREB regulated transcription coactivator 1b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
CREB regulated transcription coactivator 1b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
CREB regulated transcription coactivator 1b, transcript variant X1
CREB-regulated transcription coactivator 1b isoform X3
CREB-regulated transcription coactivator 1b isoform X2
CREB-regulated transcription coactivator 1b isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49, transcript variant X2
probable ATP-dependent RNA helicase DDX49 isoform X1
probable ATP-dependent RNA helicase DDX49 isoform X2
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated
U6 snRNA-associated Sm-like protein LSm4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cAMP-specific 3',5'-cyclic phosphodiesterase 4D-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cAMP-specific 3',5'-cyclic phosphodiesterase 4D-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cAMP-specific 3',5'-cyclic phosphodiesterase 4D-like, transcript variant X1
cAMP-specific 3',5'-cyclic phosphodiesterase 4D-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cAMP-specific 3',5'-cyclic phosphodiesterase 4D-like isoform X3
cAMP-specific 3',5'-cyclic phosphodiesterase 4D-like isoform X2
cAMP-specific 3',5'-cyclic phosphodiesterase 4D-like isoform X1
cAMP-specific 3',5'-cyclic phosphodiesterase 4D-like isoform X4
MPV17 mitochondrial inner membrane protein like 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 3% coverage of the annotated genomic feature by RNAseq alignments
adhesion G protein-coupled receptor L2a, transcript variant X1
adhesion G protein-coupled receptor L2a, transcript variant X5
adhesion G protein-coupled receptor L2a, transcript variant X3
adhesion G protein-coupled receptor L2a, transcript variant X6
adhesion G protein-coupled receptor L2a, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
adhesion G protein-coupled receptor L2a, transcript variant X4
adhesion G protein-coupled receptor L2a, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
adhesion G protein-coupled receptor L2a, transcript variant X10
adhesion G protein-coupled receptor L2a, transcript variant X2
adhesion G protein-coupled receptor L2a, transcript variant X23
adhesion G protein-coupled receptor L2a, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
adhesion G protein-coupled receptor L2a, transcript variant X24
adhesion G protein-coupled receptor L2a, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adhesion G protein-coupled receptor L2a, transcript variant X13
adhesion G protein-coupled receptor L2a, transcript variant X20
adhesion G protein-coupled receptor L2a, transcript variant X14
adhesion G protein-coupled receptor L2a, transcript variant X19
adhesion G protein-coupled receptor L2a, transcript variant X12
adhesion G protein-coupled receptor L2a, transcript variant X21
adhesion G protein-coupled receptor L2a, transcript variant X22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
adhesion G protein-coupled receptor L2a, transcript variant X15
adhesion G protein-coupled receptor L2a, transcript variant X18
adhesion G protein-coupled receptor L2a, transcript variant X16
adhesion G protein-coupled receptor L2a, transcript variant X17
adhesion G protein-coupled receptor L2 isoform X1
adhesion G protein-coupled receptor L2 isoform X5
adhesion G protein-coupled receptor L2 isoform X3
adhesion G protein-coupled receptor L2 isoform X6
adhesion G protein-coupled receptor L2 isoform X9
adhesion G protein-coupled receptor L2 isoform X4
adhesion G protein-coupled receptor L2 isoform X8
adhesion G protein-coupled receptor L2 isoform X10
adhesion G protein-coupled receptor L2 isoform X2
adhesion G protein-coupled receptor L2 isoform X18
adhesion G protein-coupled receptor L2 isoform X7
adhesion G protein-coupled receptor L2 isoform X16
adhesion G protein-coupled receptor L2 isoform X19
adhesion G protein-coupled receptor L2 isoform X17
adhesion G protein-coupled receptor L2 isoform X11
adhesion G protein-coupled receptor L2 isoform X13
adhesion G protein-coupled receptor L2 isoform X15
adhesion G protein-coupled receptor L2 isoform X12
adhesion G protein-coupled receptor L2 isoform X14
tubulin tyrosine ligase-like family, member 7
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
LOW QUALITY PROTEIN: tubulin polyglutamylase TTLL7
protein kinase, cAMP-dependent, catalytic, beta a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein kinase, cAMP-dependent, catalytic, beta a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 84 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
protein kinase, cAMP-dependent, catalytic, beta a isoform X2
protein kinase, cAMP-dependent, catalytic, beta a isoform X3
protein kinase, cAMP-dependent, catalytic, beta a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
protein kinase, cAMP-dependent, catalytic, beta a isoform X1
sterile alpha motif domain containing 13
sterile alpha motif domain-containing protein 13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
deoxyribonuclease II beta, transcript variant X1
deoxyribonuclease II beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 173 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 141 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 109 Proteins, and 23% coverage of the annotated genomic feature by RNAseq alignments
afadin- and alpha-actinin-binding protein-like, transcript variant X5
afadin- and alpha-actinin-binding protein-like, transcript variant X4
afadin- and alpha-actinin-binding protein-like, transcript variant X3
afadin- and alpha-actinin-binding protein-like, transcript variant X2
afadin- and alpha-actinin-binding protein-like, transcript variant X1
afadin- and alpha-actinin-binding protein-like isoform X4
afadin- and alpha-actinin-binding protein-like isoform X3
afadin- and alpha-actinin-binding protein-like isoform X2
afadin- and alpha-actinin-binding protein-like isoform X1
afadin- and alpha-actinin-binding protein-like isoform X5
afadin- and alpha-actinin-binding protein-like, transcript variant X6
afadin- and alpha-actinin-binding protein-like isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
calmodulin regulated spectrin-associated protein family, member 2a, transcript variant X7
calmodulin regulated spectrin-associated protein family, member 2a, transcript variant X5
calmodulin regulated spectrin-associated protein family, member 2a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
calmodulin regulated spectrin-associated protein family, member 2a, transcript variant X3
calmodulin regulated spectrin-associated protein family, member 2a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
calmodulin regulated spectrin-associated protein family, member 2a, transcript variant X1
calmodulin-regulated spectrin-associated protein 2a isoform X7
calmodulin-regulated spectrin-associated protein 2a isoform X5
calmodulin-regulated spectrin-associated protein 2a isoform X4
calmodulin-regulated spectrin-associated protein 2a isoform X3
calmodulin-regulated spectrin-associated protein 2a isoform X2
calmodulin-regulated spectrin-associated protein 2a isoform X1
calmodulin regulated spectrin-associated protein family, member 2a, transcript variant X6
calmodulin-regulated spectrin-associated protein 2a isoform X6
DEAD (Asp-Glu-Ala-Asp) box polypeptide 59
probable ATP-dependent RNA helicase DDX59
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
adhesion G-protein coupled receptor D2, transcript variant X1
adhesion G-protein coupled receptor D2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
adhesion G-protein coupled receptor D2, transcript variant X3
adhesion G-protein coupled receptor D2, transcript variant X6
adhesion G-protein coupled receptor D2, transcript variant X2
adhesion G-protein coupled receptor D2, transcript variant X4
adhesion G-protein coupled receptor D2 isoform X1
adhesion G-protein coupled receptor D2 isoform X4
adhesion G-protein coupled receptor D2 isoform X2
adhesion G-protein coupled receptor D2 isoform X5
adhesion G-protein coupled receptor D2 isoform X3
adhesion G-protein coupled receptor D2, transcript variant X7
adhesion G-protein coupled receptor D2 isoform X6
nuclear receptor subfamily 5, group A, member 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 72 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nuclear receptor subfamily 5 group A member 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protein tyrosine phosphatase receptor type C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein tyrosine phosphatase receptor type C, transcript variant X1
protein tyrosine phosphatase receptor type C, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein tyrosine phosphatase receptor type C, transcript variant X2
protein tyrosine phosphatase receptor type C, transcript variant X5
protein tyrosine phosphatase receptor type C, transcript variant X7
protein tyrosine phosphatase receptor type C, transcript variant X4
protein tyrosine phosphatase receptor type C, transcript variant X11
protein tyrosine phosphatase receptor type C, transcript variant X9
protein tyrosine phosphatase receptor type C, transcript variant X8
protein tyrosine phosphatase receptor type C, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein tyrosine phosphatase receptor type C, transcript variant X12
protein tyrosine phosphatase receptor type C, transcript variant X13
protein tyrosine phosphatase receptor type C, transcript variant X14
protein tyrosine phosphatase receptor type C, transcript variant X17
protein tyrosine phosphatase receptor type C, transcript variant X15
protein tyrosine phosphatase receptor type C, transcript variant X18
protein tyrosine phosphatase receptor type C, transcript variant X16
receptor-type tyrosine-protein phosphatase C isoform X18
receptor-type tyrosine-protein phosphatase C isoform X17
receptor-type tyrosine-protein phosphatase C isoform X15
receptor-type tyrosine-protein phosphatase C isoform X11
receptor-type tyrosine-protein phosphatase C isoform X6
receptor-type tyrosine-protein phosphatase C isoform X14
receptor-type tyrosine-protein phosphatase C isoform X9
receptor-type tyrosine-protein phosphatase C isoform X2
receptor-type tyrosine-protein phosphatase C isoform X13
receptor-type tyrosine-protein phosphatase C isoform X5
receptor-type tyrosine-protein phosphatase C isoform X8
receptor-type tyrosine-protein phosphatase C isoform X12
receptor-type tyrosine-protein phosphatase C isoform X10
receptor-type tyrosine-protein phosphatase C isoform X3
receptor-type tyrosine-protein phosphatase C isoform X7
receptor-type tyrosine-protein phosphatase C isoform X4
receptor-type tyrosine-protein phosphatase C isoform X1
receptor-type tyrosine-protein phosphatase C isoform X16
uncharacterized LOC113569073, transcript variant X2
uncharacterized LOC113569073, transcript variant X1
NIMA-related kinase 7, transcript variant X2
NIMA-related kinase 7, transcript variant X1
serine/threonine-protein kinase Nek7 isoform X2
serine/threonine-protein kinase Nek7 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DENN/MADD domain containing 1B, transcript variant X1
DENN/MADD domain containing 1B, transcript variant X2
DENN domain-containing protein 1B isoform X1
DENN domain-containing protein 1B isoform X2
crumbs cell polarity complex component 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transfer RNA isoleucine (anticodon UAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
assembly factor for spindle microtubules
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
abnormal spindle-like microcephaly-associated protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins
complement factor H-like, transcript variant X6
complement factor H-like, transcript variant X4
complement factor H-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
complement factor H-like, transcript variant X3
complement factor H-like, transcript variant X1
complement factor H-like, transcript variant X9
complement factor H-like, transcript variant X2
coagulation factor XIII B chain-like isoform X1
complement factor H-like, transcript variant X7
complement factor H-like, transcript variant X8
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase L5
ubiquitin carboxyl-terminal hydrolase isozyme L5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
regulator of G-protein signaling 21-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
regulator of G-protein signaling 21-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
regulator of G-protein signaling 21-like isoform X2
regulator of G-protein signaling 21-like isoform X1
coiled-coil domain-containing protein 50
serine/threonine-protein kinase fray2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC113582382, transcript variant X2
uncharacterized LOC113582382, transcript variant X1
uncharacterized LOC113582377, transcript variant X1
uncharacterized LOC113582377, transcript variant X2
uncharacterized protein LOC563087 homolog, transcript variant X1
uncharacterized protein LOC563087 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC563087 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
nuclear factor, interleukin 3 regulated, member 4
leucine rich repeat and Ig domain containing 3a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine rich repeat and Ig domain containing 3a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leucine rich repeat and Ig domain containing 3a, transcript variant X2
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3a
oogenesis-related gene, transcript variant X2
oogenesis-related gene, transcript variant X1
PEAK family member 3, transcript variant X1
PEAK family member 3, transcript variant X2
PEAK family member 3, transcript variant X3
inactive tyrosine-protein kinase PRAG1 isoform X1
inactive tyrosine-protein kinase PRAG1 isoform X2
inactive tyrosine-protein kinase PRAG1 isoform X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
LOW QUALITY PROTEIN: ornithine decarboxylase antizyme 1a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DOT1-like histone H3K79 methyltransferase
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: histone-lysine N-methyltransferase, H3 lysine-79 specific
elongation factor RNA polymerase II, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
elongation factor RNA polymerase II, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
RNA polymerase II elongation factor ELL isoform X2
RNA polymerase II elongation factor ELL isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
peptidyl-prolyl cis-trans isomerase FKBP8
cytokine receptor-like factor 1b, transcript variant X2
cytokine receptor-like factor 1b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cytokine receptor-like factor 1b isoform X1
cytokine receptor-like factor 1b isoform X2
required for excision 1-B domain containing
required for excision 1-B domain-containing protein
C3 and PZP like alpha-2-macroglobulin domain containing 8
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
LOW QUALITY PROTEIN: C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8
outer dense fiber of sperm tails 3-like 2b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
outer dense fiber protein 3-like protein 2b
CDC28 protein kinase regulatory subunit 2
cyclin-dependent kinases regulatory subunit 2
SHC (Src homology 2 domain containing) transforming protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ankyrin repeat domain 24, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ankyrin repeat domain 24, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ankyrin repeat domain 24, transcript variant X6
ankyrin repeat domain 24, transcript variant X7
ankyrin repeat domain 24, transcript variant X4
ankyrin repeat domain 24, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ankyrin repeat domain 24, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ankyrin repeat domain 24, transcript variant X1
ankyrin repeat domain 24, transcript variant X9
ankyrin repeat domain 24, transcript variant X8
ankyrin repeat domain 24, transcript variant X11
ankyrin repeat domain-containing protein 24 isoform X9
ankyrin repeat domain-containing protein 24 isoform X5
ankyrin repeat domain-containing protein 24 isoform X6
ankyrin repeat domain-containing protein 24 isoform X4
ankyrin repeat domain-containing protein 24 isoform X8
ankyrin repeat domain-containing protein 24 isoform X2
ankyrin repeat domain-containing protein 24 isoform X7
ankyrin repeat domain-containing protein 24 isoform X3
ankyrin repeat domain-containing protein 24 isoform X1
ankyrin repeat domain-containing protein 24 isoform X10
Src homology 2 domain containing transforming protein D, b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Src homology 2 domain containing transforming protein D, b, transcript variant X3
Src homology 2 domain containing transforming protein D, b, transcript variant X4
Src homology 2 domain containing transforming protein D, b, transcript variant X2
src homology 2 domain containing transforming protein D, b isoform X1
src homology 2 domain containing transforming protein D, b isoform X2
src homology 2 domain containing transforming protein D, b isoform X3
sphingosine-1-phosphate receptor 3a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
sphingosine-1-phosphate receptor 3a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mesoderm induction early response 1, family member 2, transcript variant X2
mesoderm induction early response 1, family member 2, transcript variant X1
mesoderm induction early response protein 2 isoform X1
mesoderm induction early response protein 2 isoform X2
uncharacterized LOC113587201, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC113587201, transcript variant X1
uncharacterized LOC113587201, transcript variant X3
phospholipid phosphatase 2b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
phospholipid phosphatase 2b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
phospholipid phosphatase 2b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transfer RNA glutamine (anticodon UUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
TLE family member 2, transcriptional corepressor a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transducin-like enhancer protein 2a isoform X1
TLE family member 2, transcriptional corepressor a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transducin-like enhancer protein 2a isoform X3
TLE family member 2, transcriptional corepressor a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transducin-like enhancer protein 2a isoform X2
TLE family member 2, transcriptional corepressor b
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
LOW QUALITY PROTEIN: transducin-like enhancer protein 4
TLE family member 5, transcriptional modulator, transcript variant X4
TLE family member 5, transcriptional modulator, transcript variant X3
TLE family member 5, transcriptional modulator, transcript variant X2
TLE family member 5, transcriptional modulator, transcript variant X1
guanine nucleotide-binding protein G(q) subunit alpha-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 213 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
guanine nucleotide-binding protein subunit alpha-11-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 211 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
guanine nucleotide-binding protein subunit alpha-11-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 211 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
guanine nucleotide-binding protein subunit alpha-11-like
uncharacterized LOC113591270, transcript variant X3
uncharacterized LOC113591270, transcript variant X2
uncharacterized LOC113591270, transcript variant X1
C2 calcium-dependent domain-containing protein 4C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
C2 calcium-dependent domain-containing protein 4C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
C2 calcium-dependent domain-containing protein 4C
cell division cycle 34 homolog (S. cerevisiae) a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
adaptor related protein complex 3 subunit delta 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
adaptor related protein complex 3 subunit delta 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
adaptor related protein complex 3 subunit delta 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
adaptor related protein complex 3 subunit delta 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
adaptor related protein complex 3 subunit delta 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
hepatoma-derived growth factor-related protein 2 isoform X2
hepatoma-derived growth factor-related protein 2 isoform X1
chromatin assembly factor 1, subunit A (p150)
secretory carrier membrane protein 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
secretory carrier membrane protein 4, transcript variant X1
secretory carrier-associated membrane protein 4 isoform X1
secretory carrier-associated membrane protein 4 isoform X2
mitogen-activated protein kinase kinase 2a, transcript variant X2
mitogen-activated protein kinase kinase 2a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
dual specificity mitogen-activated protein kinase kinase 2a isoform X1
dual specificity mitogen-activated protein kinase kinase 2a isoform X2
zinc finger and BTB domain containing 7a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 49% coverage of the annotated genomic feature by RNAseq alignments
zinc finger and BTB domain-containing protein 7A
transcription factor 3b, transcript variant X4
transcription factor 3b, transcript variant X2
transcription factor 3b, transcript variant X1
transcription factor 3b, transcript variant X3
cytochrome b-c1 complex subunit 10-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cytochrome b-c1 complex subunit 10-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
cytochrome b-c1 complex subunit 10-like, transcript variant X1
cytochrome b-c1 complex subunit 10-like, transcript variant X4
methyl-CpG binding domain protein 3b, transcript variant X7
methyl-CpG binding domain protein 3b, transcript variant X11
methyl-CpG binding domain protein 3b, transcript variant X13
methyl-CpG binding domain protein 3b, transcript variant X9
methyl-CpG binding domain protein 3b, transcript variant X15
methyl-CpG-binding domain protein 3b isoform X7
methyl-CpG-binding domain protein 3b isoform X9
methyl-CpG-binding domain protein 3b isoform X11
methyl-CpG-binding domain protein 3b isoform X13
methyl-CpG-binding domain protein 3b isoform X15
methyl-CpG binding domain protein 3b, transcript variant X1
methyl-CpG binding domain protein 3b, transcript variant X3
methyl-CpG binding domain protein 3b, transcript variant X4
methyl-CpG binding domain protein 3b, transcript variant X2
methyl-CpG binding domain protein 3b, transcript variant X8
methyl-CpG binding domain protein 3b, transcript variant X5
methyl-CpG binding domain protein 3b, transcript variant X10
methyl-CpG binding domain protein 3b, transcript variant X12
methyl-CpG binding domain protein 3b, transcript variant X14
methyl-CpG-binding domain protein 3b isoform X1
methyl-CpG-binding domain protein 3b isoform X2
methyl-CpG-binding domain protein 3b isoform X3
methyl-CpG-binding domain protein 3b isoform X4
methyl-CpG-binding domain protein 3b isoform X5
methyl-CpG-binding domain protein 3b isoform X8
methyl-CpG-binding domain protein 3b isoform X10
methyl-CpG-binding domain protein 3b isoform X12
methyl-CpG-binding domain protein 3b isoform X14
methyl-CpG binding domain protein 3b, transcript variant X6
methyl-CpG-binding domain protein 3b isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
unc-13 homolog A (C. elegans), transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
unc-13 homolog A (C. elegans), transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
unc-13 homolog A (C. elegans), transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
unc-13 homolog A (C. elegans), transcript variant X2
unc-13 homolog A (C. elegans), transcript variant X3
unc-13 homolog A (C. elegans), transcript variant X1
unc-13 homolog A (C. elegans), transcript variant X6
high mobility group 20B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
high mobility group 20B, transcript variant X2
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related
BTB (POZ) domain containing 2a, transcript variant X2
BTB/POZ domain-containing protein 2a isoform X2
BTB (POZ) domain containing 2a, transcript variant X1
BTB/POZ domain-containing protein 2a isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00440
cAMP responsive element binding protein 3-like 3a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
cyclic AMP-responsive element-binding protein 3-like protein 3-A
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 9 bases in 6 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 9 bases in 6 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: relaxin family peptide receptor 3.2b
cugbp, Elav-like family member 5a, transcript variant X1
cugbp, Elav-like family member 5a, transcript variant X4
cugbp, Elav-like family member 5a, transcript variant X2
cugbp, Elav-like family member 5a, transcript variant X3
CUGBP Elav-like family member 5a isoform X1
CUGBP Elav-like family member 5a isoform X4
CUGBP Elav-like family member 5a isoform X2
CUGBP Elav-like family member 5a isoform X3
RGM domain family, member D, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
RGM domain family, member D, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RGM domain family, member D, transcript variant X2
hydroxysteroid (11-beta) dehydrogenase 1-like a
hydroxysteroid 11-beta-dehydrogenase 1-like protein
mitochondrial contact site and cristae organizing system subunit 13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
polymerase (RNA) mitochondrial (DNA directed), transcript variant X2
polymerase (RNA) mitochondrial (DNA directed), transcript variant X1
DNA-directed RNA polymerase, mitochondrial isoform X1
DNA-directed RNA polymerase, mitochondrial isoform X2
hyperpolarization activated cyclic nucleotide-gated potassium channel 2b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2
follistatin-like 3 (secreted glycoprotein)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
CACN subunit beta associated regulatory protein b, transcript variant X3
CACN subunit beta associated regulatory protein b, transcript variant X1
CACN subunit beta associated regulatory protein b, transcript variant X2
voltage-dependent calcium channel beta subunit-associated regulatory protein isoform X2
voltage-dependent calcium channel beta subunit-associated regulatory protein isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ATP synthase subunit delta, mitochondrial
uncharacterized LOC113576215, transcript variant X1
uncharacterized LOC113576215, transcript variant X3
uncharacterized LOC113576215, transcript variant X2
cold inducible RNA binding protein b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
cold inducible RNA binding protein b, transcript variant X1
cartilage intermediate layer protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cartilage intermediate layer protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cartilage intermediate layer protein 2, transcript variant X2
cartilage intermediate layer protein 1 isoform X1
cartilage intermediate layer protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
yjeF N-terminal domain-containing protein 3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; deleted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: testis-specific serine/threonine-protein kinase 6
GATA zinc finger domain containing 2Ab, transcript variant X4
GATA zinc finger domain containing 2Ab, transcript variant X3
GATA zinc finger domain containing 2Ab, transcript variant X2
GATA zinc finger domain containing 2Ab, transcript variant X1
GATA zinc finger domain containing 2Ab isoform X3
GATA zinc finger domain containing 2Ab isoform X2
GATA zinc finger domain containing 2Ab isoform X1
GATA zinc finger domain containing 2Ab isoform X4
uncharacterized LOC113576172, transcript variant X1
uncharacterized LOC113576172, transcript variant X2
transmembrane protein 161A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transmembrane protein 161A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
transmembrane protein 161A, transcript variant X3
myocyte enhancer factor 2b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
myocyte enhancer factor 2b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
myocyte enhancer factor 2b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
BLOC-1 related complex subunit 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
BLOC-1 related complex subunit 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
BLOC-1-related complex subunit 8 isoform X2
BLOC-1-related complex subunit 8 isoform X1
regulatory factor X-associated ankyrin-containing protein, transcript variant X1
regulatory factor X-associated ankyrin-containing protein, transcript variant X2
hyaluronan and proteoglycan link protein 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transfer RNA alanine (anticodon AGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: transmembrane 6 superfamily member 2
protein strawberry notch homolog 2, transcript variant X1
protein strawberry notch homolog 2 isoform X1
uncharacterized LOC113576194, transcript variant X2
uncharacterized LOC113576194, transcript variant X1
protein strawberry notch homolog 2, transcript variant X2
protein strawberry notch homolog 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Rho GTPase activating protein 45b, transcript variant X3
rho GTPase-activating protein 45 isoform X3
Rho GTPase activating protein 45b, transcript variant X1
Rho GTPase activating protein 45b, transcript variant X2
rho GTPase-activating protein 45 isoform X1
rho GTPase-activating protein 45 isoform X2
glutathione peroxidase 4a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
glutathione peroxidase 4a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine-rich repeat flightless-interacting protein 1-like, transcript variant X2
leucine-rich repeat flightless-interacting protein 1-like, transcript variant X1
leucine-rich repeat flightless-interacting protein 1-like
abnormal spindle-like microcephaly-associated protein homolog
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 90% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: abnormal spindle-like microcephaly-associated protein homolog
p21 protein (Cdc42/Rac)-activated kinase 2b, transcript variant X2
p21 protein (Cdc42/Rac)-activated kinase 2b, transcript variant X1
serine/threonine-protein kinase PAK 2b isoform X1
serine/threonine-protein kinase PAK 2b isoform X2
phosphatidylinositol glycan anchor biosynthesis, class X
phosphatidylinositol-glycan biosynthesis class X protein
centrosomal protein 19, transcript variant X3
centrosomal protein 19, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
centrosomal protein of 19 kDa isoform X1
centrosomal protein 19, transcript variant X4
centrosomal protein 19, transcript variant X2
centrosomal protein of 19 kDa isoform X3
centrosomal protein of 19 kDa isoform X2
inhibitor of growth family, member 5a, transcript variant X1
inhibitor of growth family, member 5a, transcript variant X2
inhibitor of growth protein 5a isoform X1
inhibitor of growth protein 5a isoform X2
impact RWD domain protein, transcript variant X1
impact RWD domain protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3
lens intrinsic membrane protein 2.2, transcript variant X1
lens intrinsic membrane protein 2.2, transcript variant X2
lens intrinsic membrane protein 2.2 isoform X1
lens intrinsic membrane protein 2.2 isoform X2
GRAM domain-containing protein 2B, transcript variant X1
GRAM domain-containing protein 2B, transcript variant X2
GRAM domain-containing protein 2B isoform X1
GRAM domain-containing protein 2B isoform X2
GIPC PDZ domain containing family, member 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
thromboxane A2 receptor, transcript variant X1
thromboxane A2 receptor, transcript variant X3
thromboxane A2 receptor, transcript variant X2
protein tyrosine phosphatase receptor type Sa, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein tyrosine phosphatase receptor type Sa, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein tyrosine phosphatase receptor type Sa, transcript variant X4
protein tyrosine phosphatase receptor type Sa, transcript variant X9
protein tyrosine phosphatase receptor type Sa, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein tyrosine phosphatase receptor type Sa, transcript variant X5
protein tyrosine phosphatase receptor type Sa, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein tyrosine phosphatase receptor type Sa, transcript variant X2
protein tyrosine phosphatase receptor type Sa, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
receptor-type tyrosine-protein phosphatase S isoform X8
receptor-type tyrosine-protein phosphatase S isoform X7
receptor-type tyrosine-protein phosphatase S isoform X4
receptor-type tyrosine-protein phosphatase S isoform X9
receptor-type tyrosine-protein phosphatase S isoform X6
receptor-type tyrosine-protein phosphatase S isoform X5
receptor-type tyrosine-protein phosphatase S isoform X3
receptor-type tyrosine-protein phosphatase S isoform X2
receptor-type tyrosine-protein phosphatase S isoform X1
uncharacterized LOC113585551, transcript variant X2
uncharacterized LOC113585551, transcript variant X1
lysine (K)-specific demethylase 4B, transcript variant X2
lysine (K)-specific demethylase 4B, transcript variant X1
lysine-specific demethylase 4B isoform X2
lysine-specific demethylase 4B isoform X1
ubiquitin-like with PHD and ring finger domains 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
toll-like receptor adaptor molecule 1, transcript variant X1
toll-like receptor adaptor molecule 1, transcript variant X2
TIR domain-containing adapter molecule 1
translocase of inner mitochondrial membrane 44 homolog (yeast)
mitochondrial import inner membrane translocase subunit TIM44
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
RAD23 homolog A, nucleotide excision repair protein b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
RAD23 homolog A, nucleotide excision repair protein b, transcript variant X2
RAD23 homolog A, nucleotide excision repair protein b isoform X1
RAD23 homolog A, nucleotide excision repair protein b isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
chromosome 26 C19orf44 homolog, transcript variant X1
chromosome 26 C19orf44 homolog, transcript variant X2
chromosome 26 C19orf44 homolog, transcript variant X4
chromosome 26 C19orf44 homolog, transcript variant X3
uncharacterized protein C19orf44 homolog isoform X1
uncharacterized protein C19orf44 homolog isoform X2
calcium homeostasis endoplasmic reticulum protein, transcript variant X3
calcium homeostasis endoplasmic reticulum protein, transcript variant X2
calcium homeostasis endoplasmic reticulum protein, transcript variant X1
calcium homeostasis endoplasmic reticulum protein isoform X3
calcium homeostasis endoplasmic reticulum protein isoform X2
calcium homeostasis endoplasmic reticulum protein isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
LOW QUALITY PROTEIN: retinal homeobox protein Rx1
megakaryocyte-associated tyrosine kinase, transcript variant X2
megakaryocyte-associated tyrosine kinase, transcript variant X1
megakaryocyte-associated tyrosine-protein kinase isoform X2
megakaryocyte-associated tyrosine-protein kinase isoform X1
zinc finger RNA binding protein 2, transcript variant X5
zinc finger RNA binding protein 2, transcript variant X2
zinc finger RNA binding protein 2, transcript variant X3
zinc finger RNA binding protein 2, transcript variant X4
zinc finger RNA binding protein 2, transcript variant X1
zinc finger RNA-binding protein isoform X5
zinc finger RNA-binding protein isoform X2
zinc finger RNA-binding protein isoform X3
zinc finger RNA-binding protein isoform X4
zinc finger RNA-binding protein isoform X1
zinc finger RNA binding protein 2, transcript variant X6
zinc finger RNA-binding protein isoform X6
ATCAY kinesin light chain interacting caytaxin a
muscle-specific beta 1 integrin binding protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
muscle-specific beta 1 integrin binding protein isoform X1
muscle-specific beta 1 integrin binding protein, transcript variant X3
muscle-specific beta 1 integrin binding protein, transcript variant X2
muscle-specific beta 1 integrin binding protein isoform X2
major histocompatibility complex class I-related gene protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 23% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
myeloid-derived growth factor, transcript variant X1
myeloid-derived growth factor, transcript variant X2
myeloid-derived growth factor isoform X1
myeloid-derived growth factor isoform X2
tumor necrosis factor, alpha-induced protein 8-like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
tumor necrosis factor, alpha-induced protein 8-like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
tumor necrosis factor alpha-induced protein 8-like protein 1 isoform X1
tumor necrosis factor alpha-induced protein 8-like protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
sphingosine-1-phosphate receptor 4, transcript variant X2
sphingosine-1-phosphate receptor 4, transcript variant X1
unconventional myosin-IXb, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
unconventional myosin-IXb, transcript variant X5
unconventional myosin-IXb, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
unconventional myosin-IXb, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
unconventional myosin-IXb, transcript variant X9
unconventional myosin-IXb, transcript variant X8
unconventional myosin-IXb, transcript variant X4
unconventional myosin-IXb, transcript variant X3
unconventional myosin-IXb, transcript variant X2
unconventional SNARE in the ER 1 homolog (S. cerevisiae), transcript variant X1
unconventional SNARE in the ER 1 homolog (S. cerevisiae), transcript variant X2
vesicle transport protein USE1 isoform X1
vesicle transport protein USE1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
rho/rac guanine nucleotide exchange factor (GEF) 18b
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LOW QUALITY PROTEIN: rho guanine nucleotide exchange factor 18
uncharacterized LOC118240829, transcript variant X2
uncharacterized LOC118240829, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
translocase of inner mitochondrial membrane 13 homolog (yeast)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
mitochondrial import inner membrane translocase subunit Tim13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated
U6 snRNA-associated Sm-like protein LSm7
spindle assembly abnormal protein 6 homolog
major facilitator superfamily domain containing 14A 1
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
microtubule-associated protein 1Sa, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
microtubule-associated protein 1Sa, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
microtubule-associated protein 1Sa, transcript variant X1
cocaine- and amphetamine-regulated transcript 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cocaine- and amphetamine-regulated transcript protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
lysosome-associated membrane glycoprotein 3
methylcrotonoyl-CoA carboxylase 1 (alpha)
methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial
probable phospholipid-transporting ATPase IF, transcript variant X5
probable phospholipid-transporting ATPase IF, transcript variant X3
probable phospholipid-transporting ATPase IF isoform X5
probable phospholipid-transporting ATPase IF isoform X3
probable phospholipid-transporting ATPase IF, transcript variant X4
probable phospholipid-transporting ATPase IF, transcript variant X1
probable phospholipid-transporting ATPase IF, transcript variant X6
probable phospholipid-transporting ATPase IF, transcript variant X2
probable phospholipid-transporting ATPase IF isoform X2
probable phospholipid-transporting ATPase IF isoform X4
probable phospholipid-transporting ATPase IF isoform X1
probable phospholipid-transporting ATPase IF isoform X6
probable phospholipid-transporting ATPase IF, transcript variant X7
probable phospholipid-transporting ATPase IF isoform X7
uncharacterized LOC113577813, transcript variant X2
uncharacterized LOC113577813, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC113577813, transcript variant X1
uncharacterized LOC113577813, transcript variant X4
uncharacterized LOC113577813, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
DnaJ (Hsp40) homolog, subfamily C, member 19, transcript variant X2
mitochondrial import inner membrane translocase subunit TIM14 isoform X2
DnaJ (Hsp40) homolog, subfamily C, member 19, transcript variant X1
mitochondrial import inner membrane translocase subunit TIM14 isoform X1
fragile X mental retardation, autosomal homolog 1, transcript variant X2
fragile X mental retardation, autosomal homolog 1, transcript variant X1
fragile X mental retardation syndrome-related protein 1 isoform X2
fragile X mental retardation syndrome-related protein 1 isoform X1
tetratricopeptide repeat domain 14, transcript variant X1
tetratricopeptide repeat domain 14, transcript variant X2
tetratricopeptide repeat protein 14 isoform X1
tetratricopeptide repeat domain 14, transcript variant X3
tetratricopeptide repeat protein 14 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
26S proteasome non-ATPase regulatory subunit 1
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LOW QUALITY PROTEIN: 5-hydroxytryptamine receptor 2B
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2-like, transcript variant X5
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2-like, transcript variant X2
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2-like isoform X5
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2-like isoform X2
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2-like, transcript variant X4
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2-like, transcript variant X3
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2-like, transcript variant X1
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2-like isoform X4
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2-like isoform X3
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2-like isoform X1
protein phosphatase 1, regulatory (inhibitor) subunit 2, transcript variant X1
protein phosphatase 1, regulatory (inhibitor) subunit 2, transcript variant X5
protein phosphatase 1, regulatory (inhibitor) subunit 2, transcript variant X3
protein phosphatase 1, regulatory (inhibitor) subunit 2, transcript variant X2
protein phosphatase inhibitor 2 isoform X1
protein phosphatase inhibitor 2 isoform X4
protein phosphatase 1, regulatory (inhibitor) subunit 2, transcript variant X4
protein phosphatase inhibitor 2 isoform X3
protein phosphatase inhibitor 2 isoform X2
alkaline phosphatase, intestinal, tandem duplicate 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
alkaline phosphatase, intestinal, tandem duplicate 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 40% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 isoform X1
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 isoform X2
lisH domain-containing protein ARMC9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
lisH domain-containing protein ARMC9, transcript variant X1
lisH domain-containing protein ARMC9 isoform X1
lisH domain-containing protein ARMC9 isoform X2
RNA polymerase II, I and III subunit H, transcript variant X1
RNA polymerase II, I and III subunit H, transcript variant X2
DNA-directed RNA polymerases I, II, and III subunit RPABC3
major facilitator superfamily domain containing 8-like 1
major facilitator superfamily domain-containing protein 8
ephrin type-B receptor 3, transcript variant X7
ephrin type-B receptor 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ephrin type-B receptor 3, transcript variant X2
ephrin type-B receptor 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ephrin type-B receptor 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 71 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ephrin type-B receptor 3, transcript variant X5
ephrin type-B receptor 3, transcript variant X1
hydroxylysine kinase, tandem duplicate 2, transcript variant X1
hydroxylysine kinase, tandem duplicate 2, transcript variant X4
hydroxylysine kinase, tandem duplicate 2, transcript variant X3
hydroxylysine kinase, tandem duplicate 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins
rubicon autophagy regulator, transcript variant X1
rubicon autophagy regulator, transcript variant X2
rubicon autophagy regulator, transcript variant X3
rubicon autophagy regulator, transcript variant X4
run domain Beclin-1-interacting and cysteine-rich domain-containing protein isoform X1
run domain Beclin-1-interacting and cysteine-rich domain-containing protein isoform X2
run domain Beclin-1-interacting and cysteine-rich domain-containing protein isoform X3
run domain Beclin-1-interacting and cysteine-rich domain-containing protein isoform X4
rubicon autophagy regulator, transcript variant X5
run domain Beclin-1-interacting and cysteine-rich domain-containing protein isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 7% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC113575414, transcript variant X6
uncharacterized LOC113575414, transcript variant X4
uncharacterized LOC113575414, transcript variant X5
uncharacterized LOC113575414, transcript variant X2
uncharacterized LOC113575414, transcript variant X3
uncharacterized LOC113575414, transcript variant X1
uncharacterized LOC113575414, transcript variant X7
uncharacterized protein LOC113575414 isoform X3
uncharacterized protein LOC113575414 isoform X2
uncharacterized protein LOC113575414 isoform X1
uncharacterized protein LOC113575414 isoform X4
Tctex1 domain containing 2, transcript variant X4
tctex1 domain-containing protein 2 isoform X4
Tctex1 domain containing 2, transcript variant X2
tctex1 domain-containing protein 2 isoform X2
Tctex1 domain containing 2, transcript variant X1
Tctex1 domain containing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
tctex1 domain-containing protein 2 isoform X1
tctex1 domain-containing protein 2 isoform X3
ring finger protein 13, transcript variant X3
ring finger protein 13, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ring finger protein 13, transcript variant X2
ring finger protein 13, transcript variant X4
E3 ubiquitin-protein ligase RNF13 isoform X2
E3 ubiquitin-protein ligase RNF13 isoform X1
E3 ubiquitin-protein ligase RNF13 isoform X3
reticulocalbin 1, EF-hand calcium binding domain, transcript variant X2
reticulocalbin 1, EF-hand calcium binding domain, transcript variant X1
adaptor related protein complex 1 subunit sigma 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2
U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2
retinoblastoma binding protein 4, like, transcript variant X1
retinoblastoma binding protein 4, like, transcript variant X3
retinoblastoma binding protein 4, like, transcript variant X2
retinoblastoma binding protein 4, like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
histone-binding protein RBBP7 isoform X1
histone-binding protein RBBP7 isoform X3
histone-binding protein RBBP7 isoform X2
histone-binding protein RBBP7 isoform X4
regulator of telomere elongation helicase 1
zinc finger, CCCH-type with G patch domain
zinc finger CCCH-type with G patch domain-containing protein
cholinergic receptor, nicotinic, alpha 4b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cholinergic receptor, nicotinic, alpha 4b, transcript variant X2
neuronal acetylcholine receptor subunit alpha-4b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 8% coverage of the annotated genomic feature by RNAseq alignments
basic transcription factor 3-like 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
basic transcription factor 3-like 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
zinc finger, FYVE domain containing 9b, transcript variant X1
zinc finger, FYVE domain containing 9b, transcript variant X3
zinc finger, FYVE domain containing 9b, transcript variant X4
zinc finger, FYVE domain containing 9b, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger, FYVE domain containing 9b, transcript variant X2
zinc finger FYVE domain-containing protein 9 isoform X3
zinc finger FYVE domain-containing protein 9 isoform X4
zinc finger FYVE domain-containing protein 9 isoform X1
zinc finger FYVE domain-containing protein 9 isoform X2
ELOVL fatty acid elongase 1b, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ELOVL fatty acid elongase 1b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ELOVL fatty acid elongase 1b, transcript variant X1
ELOVL fatty acid elongase 1b, transcript variant X4
ELOVL fatty acid elongase 1b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
elongation of very long chain fatty acids protein 1b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
MAPK interacting serine/threonine kinase 1, transcript variant X1
MAPK interacting serine/threonine kinase 1, transcript variant X2
MAP kinase-interacting serine/threonine-protein kinase 1 isoform X1
MAP kinase-interacting serine/threonine-protein kinase 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ATP synthase subunit beta, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ATP-binding cassette, sub-family B (MDR/TAP), member 11b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
microtubule associated serine/threonine kinase 3b, transcript variant X3
microtubule associated serine/threonine kinase 3b, transcript variant X1
microtubule associated serine/threonine kinase 3b, transcript variant X2
microtubule-associated serine/threonine-protein kinase 3 isoform X3
microtubule-associated serine/threonine-protein kinase 3 isoform X1
microtubule-associated serine/threonine-protein kinase 3 isoform X2
homer scaffold protein 3b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
homer scaffold protein 3b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
homer scaffold protein 3b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
arrestin domain containing 2, transcript variant X2
arrestin domain-containing protein 2 isoform X2
arrestin domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
arrestin domain-containing protein 2 isoform X1
uncharacterized si:ch211-1a19.3, transcript variant X2
uncharacterized si:ch211-1a19.3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized protein si:ch211-1a19.3 isoform X1
uncharacterized protein si:ch211-1a19.3 isoform X2
glutamate receptor, ionotropic, N-methyl-D-aspartate 3Bb
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
transmembrane protein 259, transcript variant X1
transmembrane protein 259, transcript variant X2
mediator of RNA polymerase II transcription subunit 16
phospholipid phosphatase-related protein type 3
mitotic spindle positioning, transcript variant X1
mitotic spindle positioning, transcript variant X2
mitotic interactor and substrate of PLK1 isoform X1
mitotic interactor and substrate of PLK1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
polypyrimidine tract binding protein 1b, transcript variant X1
polypyrimidine tract-binding protein 1b isoform X1
polypyrimidine tract binding protein 1b, transcript variant X2
polypyrimidine tract-binding protein 1b isoform X2
family with sequence similarity 174 member C, transcript variant X2
family with sequence similarity 174 member C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
calcium/calmodulin-dependent protein kinase type IV
ELAV like RNA binding protein 1b, transcript variant X1
ELAV like RNA binding protein 1b, transcript variant X2
ELAV like RNA binding protein 1b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha, transcript variant X3
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha, transcript variant X4
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha, transcript variant X1
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha, transcript variant X2
small glutamine-rich tetratricopeptide repeat-containing protein alpha
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 5 bases in 4 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 5 bases in 4 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: NACHT domain- and WD repeat-containing protein 1
uncharacterized protein LOC541424 homolog, transcript variant X1
uncharacterized protein LOC541424 homolog, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: receptor expression-enhancing protein 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
APC regulator of WNT signaling pathway 2, transcript variant X3
APC regulator of WNT signaling pathway 2, transcript variant X1
APC regulator of WNT signaling pathway 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adenomatous polyposis coli protein 2 isoform X2
adenomatous polyposis coli protein 2 isoform X1
growth arrest and DNA-damage-inducible, beta a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
growth arrest and DNA-damage-inducible, beta a, transcript variant X1
growth arrest and DNA-damage-inducible, beta a isoform X2
growth arrest and DNA-damage-inducible, beta a isoform X1
La ribonucleoprotein 6, translational regulator b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 24% coverage of the annotated genomic feature by RNAseq alignments
vimentin type intermediate filament associated coiled-coil protein, transcript variant X2
vimentin type intermediate filament associated coiled-coil protein, transcript variant X1
vimentin-type intermediate filament-associated coiled-coil protein
NADH:ubiquinone oxidoreductase subunit A11
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
RAN binding protein 3a, transcript variant X2
RAN binding protein 3a, transcript variant X1
armadillo like helical domain containing 3, transcript variant X1
armadillo like helical domain containing 3, transcript variant X2
armadillo like helical domain containing 3, transcript variant X3
armadillo-like helical domain-containing protein 3 isoform X1
armadillo-like helical domain-containing protein 3 isoform X2
egl-9 family hypoxia-inducible factor 1b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
signal-induced proliferation-associated 1 like 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
signal-induced proliferation-associated 1 like 2, transcript variant X4
signal-induced proliferation-associated 1 like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
signal-induced proliferation-associated 1 like 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
signal-induced proliferation-associated 1 like 2, transcript variant X3
signal-induced proliferation-associated 1-like protein 2 isoform X3
signal-induced proliferation-associated 1-like protein 2 isoform X2
signal-induced proliferation-associated 1-like protein 2 isoform X1
uncharacterized si:dkey-238i5.2, transcript variant X3
uncharacterized si:dkey-238i5.2, transcript variant X2
uncharacterized si:dkey-238i5.2, transcript variant X1
uncharacterized protein si:dkey-238i5.2 isoform X3
uncharacterized protein si:dkey-238i5.2 isoform X2
uncharacterized protein si:dkey-238i5.2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ribosomal RNA processing protein 36 homolog
transfer RNA arginine (anticodon ACG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
phosphofurin acidic cluster sorting protein 2, transcript variant X1
phosphofurin acidic cluster sorting protein 2, transcript variant X2
phosphofurin acidic cluster sorting protein 2 isoform X1
phosphofurin acidic cluster sorting protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
MAP/microtubule affinity-regulating kinase 1, transcript variant X1
MAP/microtubule affinity-regulating kinase 1, transcript variant X3
MAP/microtubule affinity-regulating kinase 1, transcript variant X2
MAP/microtubule affinity-regulating kinase 1, transcript variant X4
serine/threonine-protein kinase MARK1 isoform X1
serine/threonine-protein kinase MARK1 isoform X3
serine/threonine-protein kinase MARK1 isoform X2
serine/threonine-protein kinase MARK1 isoform X4
uncharacterized protein LOC563955 homolog, transcript variant X2
uncharacterized protein LOC563955 homolog, transcript variant X1
REST corepressor 3, transcript variant X2
REST corepressor 3, transcript variant X1
potassium voltage-gated channel, subfamily H (eag-related), member 1b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium voltage-gated channel subfamily H member 1b
WW domain containing transcription regulator 1, transcript variant X1
WW domain containing transcription regulator 1, transcript variant X2
WW domain-containing transcription regulator protein 1 isoform X1
WW domain-containing transcription regulator protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
HPS3 biogenesis of lysosomal organelles complex 2 subunit 1
uncharacterized protein LOC563738 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 49% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC571127 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: alpha-2-HS-glycoprotein
SUMO specific peptidase 5, transcript variant X1
SUMO specific peptidase 5, transcript variant X3
SUMO specific peptidase 5, transcript variant X4
SUMO specific peptidase 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
phosphorylase kinase, alpha 2 (liver), transcript variant X1
phosphorylase kinase, alpha 2 (liver), transcript variant X4
phosphorylase kinase, alpha 2 (liver), transcript variant X3
phosphorylase kinase, alpha 2 (liver), transcript variant X2
phosphorylase b kinase regulatory subunit alpha, liver isoform isoform X1
phosphorylase b kinase regulatory subunit alpha, liver isoform isoform X4
phosphorylase b kinase regulatory subunit alpha, liver isoform isoform X3
phosphorylase b kinase regulatory subunit alpha, liver isoform isoform X2
MCF.2 cell line derived transforming sequence-like 2, transcript variant X1
MCF.2 cell line derived transforming sequence-like 2, transcript variant X5
MCF.2 cell line derived transforming sequence-like 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
MCF.2 cell line derived transforming sequence-like 2, transcript variant X2
MCF.2 cell line derived transforming sequence-like 2, transcript variant X6
MCF.2 cell line derived transforming sequence-like 2, transcript variant X7
guanine nucleotide exchange factor DBS isoform X1
guanine nucleotide exchange factor DBS isoform X5
guanine nucleotide exchange factor DBS isoform X8
guanine nucleotide exchange factor DBS isoform X2
guanine nucleotide exchange factor DBS isoform X6
guanine nucleotide exchange factor DBS isoform X7
MCF.2 cell line derived transforming sequence-like 2, transcript variant X4
guanine nucleotide exchange factor DBS isoform X4
MCF.2 cell line derived transforming sequence-like 2, transcript variant X3
guanine nucleotide exchange factor DBS isoform X3
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5a, transcript variant X1
lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase A
epithelial cell transforming 2, transcript variant X1
epithelial cell transforming 2, transcript variant X2
uncharacterized LOC113568353, transcript variant X2
uncharacterized LOC113568353, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
inactive N-acetylated-alpha-linked acidic dipeptidase-like protein 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: inactive N-acetylated-alpha-linked acidic dipeptidase-like protein 2
F-box-like/WD repeat-containing protein TBL1XR1a
calcium-activated potassium channel subunit beta-2, transcript variant X5
calcium-activated potassium channel subunit beta-2, transcript variant X1
calcium-activated potassium channel subunit beta-2, transcript variant X2
calcium-activated potassium channel subunit beta-2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
calcium-activated potassium channel subunit beta-2, transcript variant X4
calcium-activated potassium channel subunit beta-2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
calcium-activated potassium channel subunit beta-2 isoform X1
calcium-activated potassium channel subunit beta-2 isoform X2
zinc finger, matrin-type 3, transcript variant X1
zinc finger, matrin-type 3, transcript variant X2
zinc finger matrin-type protein 3 isoform X1
zinc finger matrin-type protein 3 isoform X2
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha, transcript variant X6
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha, transcript variant X5
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha, transcript variant X2
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha, transcript variant X4
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
family with sequence similarity 43 member A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
large 60S subunit nuclear export GTPase 1
probable cation-transporting ATPase 13A3 isoform X1
probable cation-transporting ATPase 13A3 isoform X2
collagen, type VI, alpha 2, transcript variant X2
collagen, type VI, alpha 2, transcript variant X3
collagen, type VI, alpha 2, transcript variant X1
uncharacterized protein LOC571260 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
NTPase, KAP family P-loop domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
NTPase KAP family P-loop domain-containing protein 1
contactin associated protein family member 5 like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
LIM and senescent cell antigen-like domains 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
LIM and senescent cell antigen-like-containing domain protein 1 isoform X2
LIM and senescent cell antigen-like domains 1, transcript variant X1
LIM and senescent cell antigen-like-containing domain protein 1 isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
thrombospondin, type I, domain containing 7Bb
thrombospondin type-1 domain-containing protein 7B
speckle type BTB/POZ protein like b, transcript variant X2
speckle type BTB/POZ protein like b, transcript variant X1
speckle type BTB/POZ protein like b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized si:ch211-227n13.3, transcript variant X1
uncharacterized si:ch211-227n13.3, transcript variant X2
uncharacterized protein si:ch211-227n13.3 isoform X1
uncharacterized protein si:ch211-227n13.3 isoform X2
solute carrier family 4 member 10a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 4 member 10a, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 4 member 10a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 4 member 10a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 4 member 10a, transcript variant X6
solute carrier family 4 member 10a, transcript variant X4
sodium-driven chloride bicarbonate exchanger isoform X2
sodium-driven chloride bicarbonate exchanger isoform X5
sodium-driven chloride bicarbonate exchanger isoform X1
sodium-driven chloride bicarbonate exchanger isoform X3
sodium-driven chloride bicarbonate exchanger isoform X6
sodium-driven chloride bicarbonate exchanger isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
26S proteasome non-ATPase regulatory subunit 14
RNA binding motif, single stranded interacting protein 1a, transcript variant X1
RNA binding motif, single stranded interacting protein 1a, transcript variant X3
RNA binding motif, single stranded interacting protein 1a, transcript variant X2
RNA binding motif, single stranded interacting protein 1a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
RNA-binding motif, single-stranded-interacting protein 1 isoform X1
RNA-binding motif, single-stranded-interacting protein 1 isoform X3
RNA-binding motif, single-stranded-interacting protein 1 isoform X2
RNA-binding motif, single-stranded-interacting protein 1 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phospholipase A2 receptor 1, transcript variant X1
phospholipase A2 receptor 1, transcript variant X4
phospholipase A2 receptor 1, transcript variant X2
phospholipase A2 receptor 1, transcript variant X3
phospholipase A2 receptor 1, transcript variant X5
secretory phospholipase A2 receptor isoform X1
secretory phospholipase A2 receptor isoform X4
secretory phospholipase A2 receptor isoform X2
secretory phospholipase A2 receptor isoform X3
secretory phospholipase A2 receptor isoform X5
phospholipase A2 receptor 1, transcript variant X6
secretory phospholipase A2 receptor isoform X6
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
lengsin, lens protein with glutamine synthetase domain
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; substituted 3 bases at 3 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
protein tyrosine phosphatase 4A1, transcript variant X1
protein tyrosine phosphatase 4A1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
HYLS1 centriolar and ciliogenesis associated, transcript variant X5
HYLS1 centriolar and ciliogenesis associated, transcript variant X3
HYLS1 centriolar and ciliogenesis associated, transcript variant X4
hydrolethalus syndrome protein 1 homolog isoform X4
hydrolethalus syndrome protein 1 homolog isoform X3
HYLS1 centriolar and ciliogenesis associated, transcript variant X2
HYLS1 centriolar and ciliogenesis associated, transcript variant X1
uncharacterized protein si:dkey-23f9.4 isoform X2
uncharacterized protein si:dkey-23f9.4 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 145 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
keratin, type I cytoskeletal 50 kDa-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
gastrin/cholecystokinin-like peptide, transcript variant X1
gastrin/cholecystokinin-like peptide, transcript variant X2
gastrin/cholecystokinin-like peptide isoform X1
gastrin/cholecystokinin-like peptide isoform X2
trafficking kinesin-binding protein 1, transcript variant X2
trafficking kinesin-binding protein 1, transcript variant X1
trafficking kinesin-binding protein 1, transcript variant X3
trafficking kinesin-binding protein 1 isoform X2
trafficking kinesin-binding protein 1 isoform X1
trafficking kinesin-binding protein 1 isoform X3
junction plakoglobin a, transcript variant X1
junction plakoglobin a, transcript variant X2
cell division cycle 6 homolog (S. cerevisiae)
WAS/WASL interacting protein family, member 2a
WAS/WASL-interacting protein family member 2
ATP-binding cassette, sub-family C (CFTR/MRP), member 10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
multidrug resistance-associated protein 7
sp2 transcription factor, transcript variant X1
sp2 transcription factor, transcript variant X2
suppressor of cytokine signaling 7, transcript variant X1
suppressor of cytokine signaling 7, transcript variant X2
suppressor of cytokine signaling 7, transcript variant X3
suppressor of cytokine signaling 7, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
suppressor of cytokine signaling 7 isoform X3
suppressor of cytokine signaling 7 isoform X1
suppressor of cytokine signaling 7 isoform X4
suppressor of cytokine signaling 7 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
39S ribosomal protein L45, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 55% coverage of the annotated genomic feature by RNAseq alignments